Charles River Laboratories International, Inc.
USD225.57
+9.82 (+4.55%)
CEO
James C. Foster
IPO Date
2000-06-23
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Country
US
Open
$214.67
Prev. Close
$215.75
Day Low
$214.67
Day High
$225.60
52W Low
$144.26
52W High
$228.88
Market Cap
$10.87B
Volume
0.91M
| 928.9 |
| 31 Dec 2023 | FY | 36.4% | 11.5% | 13.2% | 5.8% | 0.85 | 1.52 | 25.5 |
| 31 Dec 2022 | FY | 36.8% | 12.2% | 16.3% | 6.4% | 1.04 | 1.32 | 22.8 |
| 31 Dec 2021 | FY | 37.7% | 11.0% | 15.4% | 5.6% | 1.26 | 1.23 | 48.5 |
| 31 Dec 2020 | FY | 36.7% | 12.5% | 17.2% | 6.6% | 1.02 | 1.43 | 34.0 |
| 31 Dec 2019 | FY | 36.6% | 9.6% | 15.4% | 5.4% | 1.24 | 1.44 | 29.5 |
| 31 Dec 2018 | FY | 37.1% | 10.0% | 17.2% | 5.9% | 1.29 | 1.61 | 24.0 |
| 31 Dec 2017 | FY | 37.7% | 6.6% | 11.8% | 4.2% | 1.10 | 1.78 | 42.1 |
| 31 Dec 2016 | FY | 38.3% | 9.2% | 18.5% | 5.7% | 1.48 | 1.53 | 23.1 |
| -9.1 |
| 27 Sept 2025 | Q3 | 33.7% | 5.4% | 1.6% | 0.7% | 0.77 | 1.37 | 33.6 |
| 28 Jun 2025 | Q2 | 34.6% | 5.1% | 1.6% | 0.7% | 0.83 | 1.36 | 35.2 |
| 29 Mar 2025 | Q1 | 32.3% | 2.6% | 0.8% | 0.3% | 0.93 | 1.43 | 77.4 |
| 31 Dec 2024 | Q4 | 28.4% | -21.5% | -6.2% | -2.9% | 0.79 | 1.41 | -10.9 |
| 28 Sept 2024 | Q3 | 34.6% | 6.8% | 1.8% | 0.9% | 0.73 | 1.48 | 37.1 |
| 29 Jun 2024 | Q2 | 34.5% | 8.8% | 2.4% | 1.1% | 0.76 | 1.58 | 29.6 |
| 30 Mar 2024 | Q1 | 34.1% | 6.7% | 1.8% | 0.8% | 0.85 | 1.75 | 51.7 |
| 31 Dec 2023 | Q4 | 35.9% | 18.5% | 5.2% | 2.3% | 0.85 | 1.52 | 16.2 |